Načítá se...
Inhibitor of biological effects of interleukin-6 sarilumab in treatment of rheumatoid arthritis
Despite progress in pharmacotherapy, there still are urgent needs in the development of new methods of drug therapy of rheumatoid arthritis (RA). New prospects for drug therapy are currently associated with sarilumab (SAR), recently registered in the Russian Federation for the treatment of moderate...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
Remedium Group LLC
2019-12-01
|
| Edice: | Медицинский совет |
| Témata: | |
| On-line přístup: | https://www.med-sovet.pro/jour/article/view/4970 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|